Curaleaf Holdings, Inc. (CURLF) Stock Price, Quote & News - Stock Analysis (2024)

FAQs

Curaleaf Holdings, Inc. (CURLF) Stock Price, Quote & News - Stock Analysis? ›

The average price target represents 113.03% Increase from the current price of $2.84. Curaleaf Holdings's analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

The average price target represents 113.03% Increase from the current price of $2.84. Curaleaf Holdings's analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

The average one-year price target for Curaleaf Holdings, Inc. is $7.97. The forecasts range from a low of $5.22 to a high of $18.31. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.

CRLBF Stock 12 Month Forecast

Based on 2 Wall Street analysts offering 12 month price targets for Cresco Labs in the last 3 months. The average price target is $2.96 with a high forecast of $2.96 and a low forecast of $2.96. The average price target represents a 88.86% change from the last price of $1.57.

Curaleaf falling after company is sued over a labeling issue that resulted in some people ingesting THC.

Boris Jordan, Executive Chairman of Curaleaf, stated, "Consistent with our expectations, first quarter revenue grew 2% to $339 million, and we achieved a 48% adjusted gross margin. Adjusted EBITDA margin⁽¹⁾ was $77 million or 23% of sales, expanding 40bps from last year.

The average price target represents 0.11% Increase from the current price of $252.2. Progressive Corp.'s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

Total debt on the balance sheet as of June 2024 : $0.85 B.

Largest shareholders include AdvisorShares Investments LLC, MSOS - AdvisorShares Pure US Cannabis ETF, PHSTX - PUTNAM GLOBAL HEALTH CARE FUND Class A Shares, CNBS - Amplify Seymour Cannabis ETF, Albert D Mason Inc, PUTNAM VARIABLE TRUST - Putnam VT Global Health Care Fund Class IA Shares, Partners Capital Investment ...

(TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the closing of its acquisition of Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international ...

What is the earnings forecast for curlf? ›

What is CURLF EPS forecast? CURLF EPS forecast for the fiscal quarter 2024 (Q3) is -$0.06.

Curaleaf Holdings Shares Outstanding: 742.33M for June 30, 2024.

Total Valuation

CURLF has a market cap or net worth of $2.15 billion.

Curaleaf Announces Closure of Operations in California, Colorado and Oregon - Jan 26, 2023.

Our stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors. Can non-Canadian residents invest in the stock? Yes, non-Canadian residents can invest in Curaleaf.

P/E ratio as of September 2024 (TTM): -4.79

According to Curaleaf's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.79187. At the end of 2022 the company had a P/E ratio of -8.34.

Valuation metrics show that Cresco Labs Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors.

What do analysts say about Bed Bath & Beyond? Bed Bath & Beyond's analyst rating consensus is a Moderate Sell. This is based on the ratings of 2 Wall Streets Analysts.